BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//TrialSonar//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:TrialSonar · $ARWR readouts
X-WR-CALDESC:Clinical-trial primary completion dates from ClinicalTrials.go
 v\, refreshed nightly by TrialSonar. Not investment advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07037771-pcd@trialsonar.netlify.app
DTSTAMP:20261118T125025Z
DTSTART;VALUE=DATE:20270820
DTEND;VALUE=DATE:20270821
SUMMARY:zodasiran Injection readout (P3) · Arrowhead Pharmaceuticals $ARWR
DESCRIPTION:A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects W
 ith Homozygous Familial Hypercholesterolemia (YOSEMITE)\n\nPrimary complet
 ion date: 2027-08-20 (estimated)\nPhase 3 · Cardio-Met · Homozygous Fami
 lial Hypercholesterolemia\nEnrollment: 70 · Sites: 43\n\nPrimary completi
 on = last participant's primary-endpoint data collected\; topline results 
 usually follow weeks to months later. Sponsor-reported\, often an estimate
 . Not investment advice.\n\nhttps://datacutoff.com/radar.html?nct=
 NCT07037771\nhttps://clinicaltrials.gov/study/NCT07037771
URL:https://datacutoff.com/radar.html?nct=NCT07037771
CATEGORIES:Cardio-Met,Phase 3
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
